Efficacy of peginterferon α-2a and predictors of response in HBeAg-negative, genotype D-naive patients

BACKGROUND: Peginterferon (PEG-IFN) α-2a has been shown to induce a sustained virologic response (SVR) in 20–30% of “hepatitis B e antigen (HBeAg)”-negative patients. AIM: To determine the safety and efficacy of PEG-IFN α-2a in HBeAg-negative, genotype D-naive patients and to analyze the predictors...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ashgar, Hamad I., Khan, Mohammed Q., Aljumah, Abdulrahman, Sanai, Faisal M., Abdo, Ayman A., Dafalla, Mutasim M., Fagih, Mosa A., Bzeizi, Khalid I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734594/
https://www.ncbi.nlm.nih.gov/pubmed/23936583
http://dx.doi.org/10.1007/s12072-011-9319-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734594/
https://www.ncbi.nlm.nih.gov/pubmed/23936583
http://dx.doi.org/10.1007/s12072-011-9319-2

Ejemplares similares